Vitamin K Supplementation in Postmenopausal Women with Osteopenia (ECKO Trial): A Randomized Controlled Trial

نویسندگان

  • Angela M Cheung
  • Lianne Tile
  • Yuna Lee
  • George Tomlinson
  • Gillian Hawker
  • Judy Scher
  • Hanxian Hu
  • Reinhold Vieth
  • Lilian Thompson
  • Sophie Jamal
  • Robert Josse
چکیده

BACKGROUND Vitamin K has been widely promoted as a supplement for decreasing bone loss in postmenopausal women, but the long-term benefits and potential harms are unknown. This study was conducted to determine whether daily high-dose vitamin K1 supplementation safely reduces bone loss, bone turnover, and fractures. METHODS AND FINDINGS This single-center study was designed as a 2-y randomized, placebo-controlled, double-blind trial, extended for earlier participants for up to an additional 2 y because of interest in long-term safety and fractures. A total of 440 postmenopausal women with osteopenia were randomized to either 5 mg of vitamin K1 or placebo daily. Primary outcomes were changes in BMD at the lumbar spine and total hip at 2 y. Secondary outcomes included changes in BMD at other sites and other time points, bone turnover markers, height, fractures, adverse effects, and health-related quality of life. This study has a power of 90% to detect 3% differences in BMD between the two groups. The women in this study were vitamin D replete, with a mean serum 25-hydroxyvitamin D level of 77 nmol/l at baseline. Over 2 y, BMD decreased by -1.28% and -1.22% (p = 0.84) (difference of -0.06%; 95% confidence interval [CI] -0.67% to 0.54%) at the lumbar spine and -0.69% and -0.88% (p = 0.51) (difference of 0.19%; 95% CI -0.37% to 0.75%) at the total hip in the vitamin K and placebo groups, respectively. There were no significant differences in changes in BMD at any site between the two groups over the 2- to 4-y period. Daily vitamin K1 supplementation increased serum vitamin K1 levels by 10-fold, and decreased the percentage of undercarboxylated osteocalcin and total osteocalcin levels (bone formation marker). However, C-telopeptide levels (bone resorption marker) were not significantly different between the two groups. Fewer women in the vitamin K group had clinical fractures (nine versus 20, p = 0.04) and fewer had cancers (three versus 12, p = 0.02). Vitamin K supplements were well-tolerated over the 4-y period. There were no significant differences in adverse effects or health-related quality of life between the two groups. The study was not powered to examine fractures or cancers, and their numbers were small. CONCLUSIONS Daily 5 mg of vitamin K1 supplementation for 2 to 4 y does not protect against age-related decline in BMD, but may protect against fractures and cancers in postmenopausal women with osteopenia. More studies are needed to further examine the effect of vitamin K on fractures and cancers. TRIAL REGISTRATION ClinicalTrials.gov (#NCT00150969) and Current Controlled Trials (#ISRCTN61708241).

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Correction: Vitamin K Supplementation in Postmenopausal Women with Osteopenia (ECKO Trial): A Randomized Controlled Trial

(2008) A prevalent variant in PPP1R3A impairs glycogen synthesis and reduces muscle glycogen content in humans and mice. PLoS Med 5(1): e27. All of the other authors listed on this paper agree to this change in the authorship. We have contacted both Dr. Bhavana Solanky and Dr. Dinesh Deelchand, who have confirmed that it is appropriate for them to be listed as authors on the paper and that they...

متن کامل

Vitamin K to prevent fractures in older women: systematic review and economic evaluation.

OBJECTIVE To determine the clinical and cost-effectiveness of vitamin K in preventing osteoporotic fractures in postmenopausal women. DATA SOURCES Searches were conducted in May 2007 in MEDLINE, MEDLINE In-Process, EMBASE, Cochrane Database of Systematic Reviews, Cochrane Controlled Trials Register, BIOSIS, CINAHL, DARE, NHS EED and HTA databases, AMED, NRR, Science Citation Index and Current...

متن کامل

رابطه‌ی بین میزان فعالیت بدنی و میزان کلسیم مصرفی روزانه با شاخص‌های منتخب تن سنجی و میزان تراکم استخوان در زنان یائسه مراجعه کننده به مرکز تراکم استخوان شهر رشت

Background and Objective: This study was carried out to investigate the relationship between the amount of physical activity and daily calcium intake with body mass index and the amount of bone density in post-menopausal female patients. Materials and Methods: This descriptive-cross sectional study was performed on 80 post-menopausal women with mean age of 58.13±7.59 years and BMI mean of 26.69...

متن کامل

Effects of 3-mounth regular consumption of vitamin D-fortified low fat yogurt on quality of life indices in diabetic postmenopausal women: A randomized controlled clinical trial

Background and aims: Diabetes affects all physical, emotional, and psychological aspects of patient’s health. Postmenopausal diabetic women are more susceptible due to their crucial conditions. The emotional regulatory role of vitamin D may be because of the existence of its receptors distributed in brain areas involved in emotional processing and affective disorders. The aim o...

متن کامل

Effect of supplementation of calcium and vitamin D on bone mineral density and bone mineral content in peri- and post-menopause women; a double-blind, randomized, controlled trial.

BACKGROUND Osteoporosis is a serious global health problem for the future, that is why improving diagnostic methods and prevention of this disease could be helpful. OBJECTIVES To assess the effects of calcium supplementations combined with Vitamin D on bone mineral density (BMD) and bone mineral content (BMC) in a representative sample of peri- and post-menopausal women in a double-blind, a r...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • PLoS Medicine

دوره 5  شماره 

صفحات  -

تاریخ انتشار 2008